Gland Pharma Ltd.

GLAND

Market Cap
₹29,056 Cr.
P/E
44.11

Gland Pharma Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
9.81%
3yr Average
14.54%
5yr Average
16.12%
Net Profit Margin
Latest
21.55%
3yr Average
25.96%
5yr Average
25.87%
ROCE
Latest
13.9%
3yr Average
19.55%
5yr Average
21.85%
Debt to Equity
Latest
0.0
3yr Average
0.0
5yr Average
0.0
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Distribution Channel

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    • API Capacity (Kg/Year)
      Source
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Gland Pharma Ltd.
    Complete Analysis of Gland Pharma - Sadhan
    Gland Pharma Analysis - Pure play injectables player - Value Educator
    View the discussion on ValuePickr
    Corporate Governance Red Flags At Gland Pharma - Beat The Street
    The Business Risk Of Gland Pharma According to Aditya Khemka - Incred
    timeline